CILIBERTO, GENNARO
CILIBERTO, GENNARO
Dipartimento di Medicina sperimentale e clinica
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli
1992-01-01 Arcone, R.; Arpaia, G.; Ruoppolo, M.; Malorni, A.; Marino, G.; Ialenti, A.; DI ROSA, M.; Ciliberto, G
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin
1993-01-01 Toniatti, C.; Monaci, P.; Nicosia, A.; Cortese, R.; Ciliberto, G
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP)
1994-01-01 Gregory, B.; Savino, R; Ciliberto, G.
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP)
1994-01-01 Gregory, B.; Savino, R.; Ciliberto, G
A federated learning system for precision oncology in Europe: DigiONE
2024-01-01 Mahon, Piers; Chatzitheofilou, Ismini; Dekker, Andre; Fernández, Xosé; Hall, Geoff; Helland, Aslaug; Traverso, Alberto; Van Marcke, Cedric; Vehreschild, Janne; Ciliberto, Gennaro; Tonon, Giovanni
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand
2005-01-01 Gallinari, P.; Lahm, A.; Koch, U.; Paolini, C.; Nardi, Mc.; LAMARTINA S, .; Roscilli, G.; Kinzel, O.; Fattori, D.; Muraglia, E.; Toniatti, C.; Cortese, R.; De, Francesco; Ciliberto, G
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro
1983-01-01 Traboni, C.; Cortese, R.; Ciliberto, G; Cesareni, G.
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
2005-01-01 Miller, Md; Geleziunas, R; Bianchi, E; Lennard, S; Hrin, R; Zhang, H; Lu, M; An, Z; Ingallinella, P; Finotto, M; Mattu, M; Finnefrock, A; Bramhill, D; Cook, J; Eckert, D; Hampton, R; Patel, M; Jarantow, S; Joyce, J; Ciliberto, G; Cortese, R; Lu, P; Strohl, W; Schleif, W; Mcelhaugh, M; Lane, S; Lloyd, C; Lowe, D; Osburne, J; Vaughan, T; Emini, E; Barbato, G; Kim, Ps; Hazuda, D; Shiver, J; Pessi, A.
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130
1995-01-01 Savino, R; Lahm, A; Ciliberto, G
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
2020-01-01 Silvestris, N.; Apolone, G.; Botti, G.; Ciliberto, G.; Costantini, M.; De Paoli, P.; Franceschi, S.; Opocher, G.; Paradiso, A.; Pronzato, P.; Sgambato, A.; De Maria, R.
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
2019-01-01 Gamucci, T; Pizzuti, L; Natoli, C; Mentuccia, L; Sperduti, I; Barba, M; Sergi, D; Iezzi, L; Maugeri-Sacca, M; Vaccaro, A; Magnolfi, E; Gelibter, A; Barchiesi, G; Magri, V; D'Onofrio, L; Cassano, A; Rossi, E; Botticelli, A; Moscetti, L; Omarini, C; Fabbri, Ma; Scinto, Af; Corsi, D; Carbognin, L; Mazzotta, M; Bria, E; Foglietta, J; Samaritani, R; Garufi, C; Mariani, L; Barni, S; Mirabelli, R; Sarmiento, R; Graziano, V; Santini, D; Marchetti, P; Tonini, G; Di Lauro, L; Sanguineti, G; Paoletti, G; Tomao, S; De Maria, R; Veltri, E; Paris, I; Giotta, F; Latorre, A; Giordano, A; Ciliberto, G; Vici, P
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library
1994-01-01 Wallace, A.; Altamura, S.; Toniatti, C.; Vitelli, A.; Bianchi, E.; Delmastro, P.; Ciliberto, G; A., Pessi
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
2016-01-01 Tagliamonte, M; Petrizzo, A; Napolitano, M; Luciano, A; Rea, D; Barbieri, A; Arra, C; Maiolino, P; Tornesello, M; Ciliberto, G; Buonaguro, Fm; Buonaguro, L
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
2009-01-01 Peruzzi, D; Dharmapuri, S; Cirillo, A; Bruni, Be; Nicosia, A; Cortese, R; Colloca, S; Ciliberto, G; LA MONICA, N; Aurisicchio, L
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter
1982-01-01 Traboni, C.; Ciliberto, G; Cortese, R.
A novel minigene scaffold for therapeutic cancer vaccines
2014-01-01 Aurisicchio, L; Fridman, A; Bagchi, A; Scarselli, E; LA MONICA, N; Ciliberto, G
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses
2009-01-01 Conforti, A; Peruzzi, D; Gianneti, P; Biondo, A; Ciliberto, G; LA MONICA, N; Aurisicchio, L
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent
2004-01-01 Savino, R; Ciliberto, G.
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT
2004-01-01 Savino, R; Ciliberto, G
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
2022-01-01 Donzelli, Sara; Cioce, Mario; Sacconi, Andrea; Zanconato, Francesca; Daralioti, Theodora; Goeman, Frauke; Orlandi, Giulia; Di Martino, Simona; Fazio, Vito Michele; Alessandrini, Gabriele; Telera, Stefano; Carosi, Mariantonia; Ciliberto, Gennaro; Botti, Claudio; Strano, Sabrina; Piccolo, Stefano; Blandino, Giovanni
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli | 1-gen-1992 | Arcone, R.; Arpaia, G.; Ruoppolo, M.; Malorni, A.; Marino, G.; Ialenti, A.; DI ROSA, M.; Ciliberto, G | |
| A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin | 1-gen-1993 | Toniatti, C.; Monaci, P.; Nicosia, A.; Cortese, R.; Ciliberto, G | |
| A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) | 1-gen-1994 | Gregory, B.; Savino, R; Ciliberto, G. | |
| A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) | 1-gen-1994 | Gregory, B.; Savino, R.; Ciliberto, G | |
| A federated learning system for precision oncology in Europe: DigiONE | 1-gen-2024 | Mahon, Piers; Chatzitheofilou, Ismini; Dekker, Andre; Fernández, Xosé; Hall, Geoff; Helland, Aslaug; Traverso, Alberto; Van Marcke, Cedric; Vehreschild, Janne; Ciliberto, Gennaro; Tonon, Giovanni | |
| A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand | 1-gen-2005 | Gallinari, P.; Lahm, A.; Koch, U.; Paolini, C.; Nardi, Mc.; LAMARTINA S, .; Roscilli, G.; Kinzel, O.; Fattori, D.; Muraglia, E.; Toniatti, C.; Cortese, R.; De, Francesco; Ciliberto, G | |
| A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro | 1-gen-1983 | Traboni, C.; Cortese, R.; Ciliberto, G; Cesareni, G. | |
| A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope | 1-gen-2005 | Miller, Md; Geleziunas, R; Bianchi, E; Lennard, S; Hrin, R; Zhang, H; Lu, M; An, Z; Ingallinella, P; Finotto, M; Mattu, M; Finnefrock, A; Bramhill, D; Cook, J; Eckert, D; Hampton, R; Patel, M; Jarantow, S; Joyce, J; Ciliberto, G; Cortese, R; Lu, P; Strohl, W; Schleif, W; Mcelhaugh, M; Lane, S; Lloyd, C; Lowe, D; Osburne, J; Vaughan, T; Emini, E; Barbato, G; Kim, Ps; Hazuda, D; Shiver, J; Pessi, A. | |
| A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 | 1-gen-1995 | Savino, R; Lahm, A; Ciliberto, G | |
| A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? | 1-gen-2020 | Silvestris, N.; Apolone, G.; Botti, G.; Ciliberto, G.; Costantini, M.; De Paoli, P.; Franceschi, S.; Opocher, G.; Paradiso, A.; Pronzato, P.; Sgambato, A.; De Maria, R. | |
| A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study | 1-gen-2019 | Gamucci, T; Pizzuti, L; Natoli, C; Mentuccia, L; Sperduti, I; Barba, M; Sergi, D; Iezzi, L; Maugeri-Sacca, M; Vaccaro, A; Magnolfi, E; Gelibter, A; Barchiesi, G; Magri, V; D'Onofrio, L; Cassano, A; Rossi, E; Botticelli, A; Moscetti, L; Omarini, C; Fabbri, Ma; Scinto, Af; Corsi, D; Carbognin, L; Mazzotta, M; Bria, E; Foglietta, J; Samaritani, R; Garufi, C; Mariani, L; Barni, S; Mirabelli, R; Sarmiento, R; Graziano, V; Santini, D; Marchetti, P; Tonini, G; Di Lauro, L; Sanguineti, G; Paoletti, G; Tomao, S; De Maria, R; Veltri, E; Paris, I; Giotta, F; Latorre, A; Giordano, A; Ciliberto, G; Vici, P | |
| A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library | 1-gen-1994 | Wallace, A.; Altamura, S.; Toniatti, C.; Vitelli, A.; Bianchi, E.; Delmastro, P.; Ciliberto, G; A., Pessi | |
| A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice | 1-gen-2016 | Tagliamonte, M; Petrizzo, A; Napolitano, M; Luciano, A; Rea, D; Barbieri, A; Arra, C; Maiolino, P; Tornesello, M; Ciliberto, G; Buonaguro, Fm; Buonaguro, L | |
| A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines | 1-gen-2009 | Peruzzi, D; Dharmapuri, S; Cirillo, A; Bruni, Be; Nicosia, A; Cortese, R; Colloca, S; Ciliberto, G; LA MONICA, N; Aurisicchio, L | |
| A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter | 1-gen-1982 | Traboni, C.; Ciliberto, G; Cortese, R. | |
| A novel minigene scaffold for therapeutic cancer vaccines | 1-gen-2014 | Aurisicchio, L; Fridman, A; Bagchi, A; Scarselli, E; LA MONICA, N; Ciliberto, G | |
| A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses | 1-gen-2009 | Conforti, A; Peruzzi, D; Gianneti, P; Biondo, A; Ciliberto, G; LA MONICA, N; Aurisicchio, L | |
| A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent | 1-gen-2004 | Savino, R; Ciliberto, G. | |
| A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT | 1-gen-2004 | Savino, R; Ciliberto, G | |
| A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions | 1-gen-2022 | Donzelli, Sara; Cioce, Mario; Sacconi, Andrea; Zanconato, Francesca; Daralioti, Theodora; Goeman, Frauke; Orlandi, Giulia; Di Martino, Simona; Fazio, Vito Michele; Alessandrini, Gabriele; Telera, Stefano; Carosi, Mariantonia; Ciliberto, Gennaro; Botti, Claudio; Strano, Sabrina; Piccolo, Stefano; Blandino, Giovanni |